332 related articles for article (PubMed ID: 29169653)
1. [How to manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)].
Brissot E; Alsuliman T; Gruson B; Hermet E; Tirefort Y; Yakoub-Agha I; Alain S
Bull Cancer; 2017 Dec; 104(12S):S181-S187. PubMed ID: 29169653
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report].
Bay JO; Peffault de Latour R; Bruno B; Coiteux V; Guillaume T; Hicheri Y; Paillard C; Suarez F; Turlure P; Alain S; Bulabois CE; Socié G; Bauters F; Yakoub-Agha I;
Pathol Biol (Paris); 2013 Aug; 61(4):152-4. PubMed ID: 24011961
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.
Zallio F; Primon V; Tamiazzo S; Pini M; Baraldi A; Corsetti MT; Gotta F; Bertassello C; Salvi F; Rocchetti A; Levis A
Clin Transplant; 2013; 27(4):E491-7. PubMed ID: 23781897
[TBL] [Abstract][Full Text] [Related]
4. [How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: an SFGM-TC report on pre-transplant cytomegalovirus, Epstein-Barr virus, Toxoplasma gondii, or syphilis IgM positive serology test].
Duléry R; Giraud C; Beaumont JL; Bilger K; Borel C; Dhedin N; Thiebaut A; Willems E; Alain S; Alfandari S; Dewilde A; Jouet JP; Milpied N; Yakoub-Agha I;
Pathol Biol (Paris); 2013 Aug; 61(4):155-7. PubMed ID: 24011960
[TBL] [Abstract][Full Text] [Related]
5. [How I manage respiratory syncytial virus, human herpesvirus 6 and adenovirus reactivation or infection after allogeneic stem cell transplantation: a report of the SFGM-TC].
Deconinck E; Dalle JH; Berceanu A; Chevallier P; Duléry R; Garnier A; Huynh A; Labussière-Wallet H; Nguyen Quoc S; Dewilde A; Ramon P; Yakoub-Agha I;
Pathol Biol (Paris); 2013 Aug; 61(4):149-51. PubMed ID: 24011959
[TBL] [Abstract][Full Text] [Related]
6. Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation.
Zhou JR; Shi DY; Wei R; Wang Y; Yan CH; Zhang XH; Xu LP; Liu KY; Huang XJ; Sun YQ
Front Immunol; 2020; 11():620891. PubMed ID: 33664733
[TBL] [Abstract][Full Text] [Related]
7. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the shedding of three β-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up.
Dzieciatkowski T; Tomaszewska A; Przybylski M; Rusicka P; Basak GW; Jedrzejczak WW; Wroblewska M; Halaburda K
J Clin Virol; 2016 Mar; 76():30-5. PubMed ID: 26809130
[TBL] [Abstract][Full Text] [Related]
9. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
10. Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor.
Crocchiolo R; Giordano L; Rimondo A; Bologna M; Sarina B; Morabito L; Bramanti S; Castagna L; Mineri R
J Clin Virol; 2016 Nov; 84():24-26. PubMed ID: 27669362
[TBL] [Abstract][Full Text] [Related]
11. Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation.
Jaskula E; Dlubek D; Sedzimirska M; Duda D; Tarnowska A; Lange A
Transplant Proc; 2010 Oct; 42(8):3273-6. PubMed ID: 20970670
[TBL] [Abstract][Full Text] [Related]
12. [Clinical Study of Allogeneic Hematopoietic Stem Cell Transplantation Patients with Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus].
Wang ZW; Liu Q; Sun HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):561-567. PubMed ID: 38660867
[TBL] [Abstract][Full Text] [Related]
13. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
[TBL] [Abstract][Full Text] [Related]
14. High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for adult T cell leukemia.
Ogata M; Satou T; Kawano R; Yoshikawa T; Ikewaki J; Kohno K; Ando T; Miyazaki Y; Ohtsuka E; Saburi Y; Kikuchi H; Saikawa T; Kadota J
J Med Virol; 2011 Apr; 83(4):702-9. PubMed ID: 21328386
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.
Ding Y; Ru Y; Song T; Guo L; Zhang X; Zhu J; Li C; Jin Z; Huang H; Tu Y; Xu M; Xu Y; Chen J; Wu D
Ann Hematol; 2021 Nov; 100(11):2773-2785. PubMed ID: 34480615
[TBL] [Abstract][Full Text] [Related]
16. [Antiviral prophylaxis for CMV, HSV/VZV and HBV in allogeneic hematopoietic cell transplantation in adult patients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Brissot E; Alsuliman T; Beauvais D; Bonnin A; Mear JB; Souchet L; Villate A; Yakoub-Agha I; Bazarbachi A
Bull Cancer; 2020 Jan; 107(1S):S1-S6. PubMed ID: 31627903
[TBL] [Abstract][Full Text] [Related]
17. Study on reactivation of herpes family of viruses in cutaneous adverse drug reactions.
Sasidharanpillai S; Riyaz N; Khader A; Rajan U; Binitha MP; Arunkumar G
Indian J Dermatol Venereol Leprol; 2013; 79(5):725. PubMed ID: 23974598
[No Abstract] [Full Text] [Related]
18. Simultaneous monitoring by real-time polymerase chain reaction of epstein-barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients.
Ono Y; Ito Y; Kaneko K; Shibata-Watanabe Y; Tainaka T; Sumida W; Nakamura T; Kamei H; Kiuchi T; Ando H; Kimura H
Transplant Proc; 2008 Dec; 40(10):3578-82. PubMed ID: 19100443
[TBL] [Abstract][Full Text] [Related]
19. High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis.
Pischke S; Gösling J; Engelmann I; Schlue J; Wölk B; Jäckel E; Meyer-Heithuis C; Lehmann U; Strassburg CP; Barg-Hock H; Becker T; Manns MP; Schulz T; Wedemeyer H; Heim A
J Hepatol; 2012 May; 56(5):1063-1069. PubMed ID: 22245897
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay.
Wada K; Kubota N; Ito Y; Yagasaki H; Kato K; Yoshikawa T; Ono Y; Ando H; Fujimoto Y; Kiuchi T; Kojima S; Nishiyama Y; Kimura H
J Clin Microbiol; 2007 May; 45(5):1426-32. PubMed ID: 17376882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
